Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.7M Sell
4,820
-12,472
-72% -$4.45M 0.11% 116
2025
Q4
$5.66M Sell
17,292
-1
-0% -$317 0.22% 114
2025
Q3
$4.88M Sell
17,293
-228
-1% -$66.1K 0.19% 130
2025
Q2
$4.89M Buy
17,521
+358
+2% +$101K 0.18% 121
2025
Q1
$5.35M Sell
17,163
-248
-1% -$73.2K 0.21% 93
2024
Q4
$4.54M Buy
17,411
+3,818
+28% +$1.13M 0.17% 125
2024
Q3
$6.83M Sell
13,593
-1,163
-8% -$380K 0.21% 148
2024
Q2
$4.61M Buy
+14,756
New +$4.34M 0.17% 163
2021
Q2
Sell
-1,287
Closed -$320K 67
2021
Q1
$320K Buy
1,287
+392
+44% +$93.5K 0.25% 55
2020
Q4
$206K Buy
+895
New +$206K 0.18% 58

Other funds holding AMGN

F/M Investments's AMGN Position: Q1 2026 in Review

F/M Investments reduced its Amgen (AMGN) stake by 72% in Q1 2026, selling an estimated $4.45M and leaving 4,820 shares worth $1.7M. The position accounts for 0.11% of the portfolio, ranked #116.

F/M Investments first reported a position in AMGN in Q4 2020 and has held it in 10 quarters since. The position peaked at $6.83M in Q3 2024. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • F/M Investments held 4,820 shares of Amgen worth $1.7M as of Q1 2026.
  • F/M Investments sold 12,472 Amgen shares in Q1 2026, an estimated $4.45M.
  • Amgen made up 0.11% of F/M Investments's portfolio in Q1 2026, its #116 holding.
  • F/M Investments first reported a position in Amgen in Q4 2020 and has held it in 10 quarters since.
  • F/M Investments's Amgen position peaked at $6.83M in Q3 2024.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on F/M Investments's 13F filing for Q1 2026, filed 11 May 2026.